Retatrutide is a novel drug that belongs to the class of glucagon-like peptide-1 (GLP-1) receptor agonists. This emerging treatment has gained significant traction in the medical community for its potential to https://jonaskjgm377052.mpeblog.com/66014388/retatrutide-a-new-dawn-in-glp-1-weight-loss